Therapentin-60
Product Images NDC 68405-680

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Therapentin-60 (NDC 68405-680). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physician Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 Weekly Mean Pain Scores (Figure 1 Weeklymeanpainscores)

Figure-1 Weekly Mean Pain Scores (Figure 1 Weeklymeanpainscores)
The text seems to be a snippet from a clinical study report on the effect of gabapentin on pain relief. It includes a chart showing the weekly mean pain scores for observed cases in the intent-to-treat (ITT) population over several weeks. The treatment involves a dose of 3600 gy of gabapentin. The rest of the text is difficult to interpret, possibly due to errors.*
FDA Label Image

Figure-2 Weekly Mean Pain Scores (Figure 2 Weeklymeanpainscores)

Figure-2 Weekly Mean Pain Scores (Figure 2 Weeklymeanpainscores)
The text contains medication dosages, a pain score and a figure reference for a study. It is not enough to provide a useful description.*
FDA Label Image

Figure-3 Proportion Of Responders (Figure 3 Proportionofresponders)

Figure-3 Proportion Of Responders (Figure 3 Proportionofresponders)
The text presents data from two studies (Study 1 and Study 2) about the percentage of responders at endpoint, specifically patients with 250% reduction in pain score, in controlled PHN studies. The two studies are represented graphically in Figure 3, which shows the proportion of responders for two different treatments (Control and Experimental) in patients with PHN. Therefore, this text would be useful for those interested in analyzing the efficacy of different treatments for PHN patients.*
FDA Label Image

Figure-4 Responder Rate (Figure 4 Responderrate)

FDA Label Image

Gabapentin (Gabapentin)

Gabapentin (Gabapentin)
This is a description of a medication called Gabapentin 300mg Capsule manufactured by Camber Pharm. It comes with caution and should be taken as directed by the doctor. The lot number is GBC323QE with an expiry date of 0313. This medication is compared to Neurontin and the packaging has dosage information inside. The lot numbers for Neurontin are 31722022206 and 31722022208 respectively. The manufacturer is M e Co. from Niperre, GA 334.*
FDA Label Image

Gabapentin Capsules Structural Formula (Gabapentincapsulesstructuralformula)

FDA Label Image

Theramine Medical Food-60 Capsules (Theraminemedicalfood 60capsules)

Theramine Medical Food-60 Capsules (Theraminemedicalfood 60capsules)
This appears to be a description of a medical food product called "Theramine". The product is intended for use by adults only under physician supervision and is designed for the dietary management of Myalgha. It contains a proprietary blend of amino acids, proteins, and natural extracts, and contains no added sugar, starch, wheat, yeast, or artificial flavors. Each serving consists of 1-2 capsules and should be taken every four hours or as directed by a physician. The product should be stored in a cool, dry place and kept out of the reach of children. The product is distributed by Physicians Therapeutics in Lox Anate, CA.*
FDA Label Image

Therapentin-60 (Therapentin 60)

Therapentin-60 (Therapentin 60)
Therapentin-60 is a medical food and drug that offers convenience through its combination of Theramineā„¢ 60 capsules and Gabapentin 300 mg 60 capsules. It is only available with a prescription, and refills can only be obtained with an NDC# 68405-680-26 and physician authorization.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.